TCS 2312Potent Chk1 inhibitor CAS# 838823-31-7 |
- CYT387 sulfate salt
Catalog No.:BCC1506
CAS No.:1056636-06-6
- Baricitinib phosphate
Catalog No.:BCC1401
CAS No.:1187595-84-1
- JAK2 Inhibitor V, Z3
Catalog No.:BCC1667
CAS No.:195371-52-9
- Bardoxolone methyl
Catalog No.:BCC1400
CAS No.:218600-53-4
- Ruxolitinib (INCB018424)
Catalog No.:BCC1276
CAS No.:941678-49-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 838823-31-7 | SDF | Download SDF |
PubChem ID | 11258443 | Appearance | Powder |
Formula | C25H24N4O2 | M.Wt | 412.48 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 20 mM in DMSO | ||
Chemical Name | 4-[4-[5-[4-[(cyclopropylamino)methyl]anilino]-1,2-dihydropyrazol-3-ylidene]cyclohexa-2,5-dien-1-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one | ||
SMILES | C1CC1NCC2=CC=C(C=C2)NC3=CC(=C4C=CC(=C5C=CC(=O)C=C5O)C=C4)NN3 | ||
Standard InChIKey | BYFCMDWKTJJQGR-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C25H24N4O2/c30-21-11-12-22(24(31)13-21)17-3-5-18(6-4-17)23-14-25(29-28-23)27-20-7-1-16(2-8-20)15-26-19-9-10-19/h1-8,11-14,19,26-29,31H,9-10,15H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent and selective checkpoint kinase 1 (chk1) inhibitor (Ki = 0.38 nM, EC50 = 60 nM). Enhances the cell killing activity of Gemcitabine in breast and prostate cancer cell lines and displays antiproliferative effects in vitro. |
TCS 2312 Dilution Calculator
TCS 2312 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4244 mL | 12.1218 mL | 24.2436 mL | 48.4872 mL | 60.609 mL |
5 mM | 0.4849 mL | 2.4244 mL | 4.8487 mL | 9.6974 mL | 12.1218 mL |
10 mM | 0.2424 mL | 1.2122 mL | 2.4244 mL | 4.8487 mL | 6.0609 mL |
50 mM | 0.0485 mL | 0.2424 mL | 0.4849 mL | 0.9697 mL | 1.2122 mL |
100 mM | 0.0242 mL | 0.1212 mL | 0.2424 mL | 0.4849 mL | 0.6061 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- WIKI4
Catalog No.:BCC2455
CAS No.:838818-26-1
- Cetirizine DiHCl
Catalog No.:BCC4517
CAS No.:83881-52-1
- Cetirizine
Catalog No.:BCC1469
CAS No.:83881-51-0
- Obovatol
Catalog No.:BCN8265
CAS No.:83864-78-2
- Angeloylisogomisin O
Catalog No.:BCN4379
CAS No.:83864-70-4
- Angeloylgomisin O
Catalog No.:BCN7361
CAS No.:83864-69-1
- 4-Benzoyl 4'-methyldiphenyl sulfide
Catalog No.:BCC8694
CAS No.:83846-85-9
- 2-Ethylhexyl trans-4-methoxycinnamate
Catalog No.:BCN1333
CAS No.:83834-59-7
- Falecalcitriol
Catalog No.:BCC1570
CAS No.:83805-11-2
- Fmoc-Ser(Bzl)-OH
Catalog No.:BCC3542
CAS No.:83792-48-7
- Fmoc-Arg(Tos)-OH
Catalog No.:BCC3076
CAS No.:83792-47-6
- YM 244769
Catalog No.:BCC6222
CAS No.:837424-39-2
- Azithromycin
Catalog No.:BCC4385
CAS No.:83905-01-5
- Gramodendrine
Catalog No.:BCN2155
CAS No.:83905-67-3
- 12-Acetoxyabietic acid
Catalog No.:BCN4380
CAS No.:83905-81-1
- 13-Hydroxylabda-8(17),14-dien-18-oic acid
Catalog No.:BCN1332
CAS No.:83915-59-7
- Isogomisin O
Catalog No.:BCN4381
CAS No.:83916-76-1
- Mometasone furoate
Catalog No.:BCC4801
CAS No.:83919-23-7
- Flavidin
Catalog No.:BCN6438
CAS No.:83924-98-5
- Flavidinin
Catalog No.:BCN3599
CAS No.:83925-00-2
- 4-Epicommunic acid
Catalog No.:BCN4382
CAS No.:83945-57-7
- GNF-7
Catalog No.:BCC6529
CAS No.:839706-07-9
- Pluripotin
Catalog No.:BCC6178
CAS No.:839707-37-8
- 2,7-Dimethyl-1,4-dihydroxynaphthalene 1-O-glucoside
Catalog No.:BCN7611
CAS No.:839711-70-5
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.[Pubmed:17887663]
J Med Chem. 2007 Nov 1;50(22):5253-6.
The cocrystal structure of a library hit was used to design a novel series of CHK1 inhibitors. The new series retained the critical hydrogen-bonding groups of the resorcinol moiety for binding but lacked the phenolic anilide moiety. The newly designed compounds exhibited similar enzymatic activity, while demonstrating increased cellular potency. Compound 10c, showing no single agent effect, potentiated the antiproliferative effect of Gemcitabine in both prostate and breast cancer cell lines.